Literature DB >> 922325

Viruses and cardiomyopathy.

.   

Abstract

Entities:  

Mesh:

Year:  1977        PMID: 922325      PMCID: PMC1631696     

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  9 in total

1.  Clinical and experimental studies on cardiomyopathy.

Authors:  C Kawai; T Takatsu
Journal:  N Engl J Med       Date:  1975-09-18       Impact factor: 91.245

2.  Viral and rickettsial causes of cardiac disease, including the Coxsackie virus etiology of pericarditis and myocarditis.

Authors:  T E WOODWARD; F R McCRUMB; T N CAREY; Y TOGO
Journal:  Ann Intern Med       Date:  1960-12-15       Impact factor: 25.391

3.  Observations on the A2 England influenza epidemic: a clinicopathological study.

Authors:  D Verel; A J Warrack; C W Potter; C Ward; D F Rickards
Journal:  Am Heart J       Date:  1976-09       Impact factor: 4.749

4.  Symptomless myocarditis and myalgia in viral and Mycoplasma pneumoniae infections.

Authors:  D Lewes; D J Rainford; W F Lane
Journal:  Br Heart J       Date:  1974-09

Review 5.  Adult heart disease due to the Coxsackie virus B infection.

Authors:  G S Sainani; E Krompotic; S J Slodki
Journal:  Medicine (Baltimore)       Date:  1968-03       Impact factor: 1.889

6.  Arbovirus heart disease: myocarditis and cardiomyopathy following dengue and chikungunya fever--a follow-up study.

Authors:  I Obeyesekere; Y Hermon
Journal:  Am Heart J       Date:  1973-02       Impact factor: 4.749

7.  T-wave abnormalities during hyperventilation and isoproterenol infusion.

Authors:  L Biberman; R N Sarma; B Surawicz
Journal:  Am Heart J       Date:  1971-02       Impact factor: 4.749

8.  Residual pathologic changes following murine coxsackie A and B myocarditis.

Authors:  F M Wilson; Q R Miranda; J L Chason; A M Lerner
Journal:  Am J Pathol       Date:  1969-05       Impact factor: 4.307

Review 9.  Intrauterine virus infections and congenital heart disease.

Authors:  J C Overall
Journal:  Am Heart J       Date:  1972-12       Impact factor: 4.749

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.